ABL127

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

ABL127  纯度: 99.86%

ABL127 是一个有选择且共价的蛋白质甲基酯酶 1 (PME-1) 抑制剂,在 HEK293T 和 MDA-MB-231 细胞中的 IC50 值分别为 6.4 和 4.2 nM。

ABL127

ABL127 Chemical Structure

CAS No. : 1073529-41-5

规格 价格 是否有货 数量
5 mg ¥2100 询价
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

ABL127 相关产品

相关化合物库:

  • Covalent Screening Library Plus
  • Bioactive Compound Library Plus
  • Anti-Cancer Compound Library
  • Covalent Screening Library
  • Targeted Diversity Library

生物活性

ABL127 is a selective and covalent inhibitor of protein methylesterase 1 (PME-1) with IC50s of 6.4 nM and 4.2 nM in HEK293T and MDA-MB-231 cells, respectively.

IC50 & Target

IC50: 6.4 nM (PME-1 in HEK293T), 4.2 nM (PME-1 in MDA-MB-231)[1]

体外研究
(In Vitro)

Three described PME-1 inhibitors are tested in this assay and a thermal shift with 100 μM ABL127 is detected. Using 25 or 50 μM ABL127 also shows a shift in protein melting temperature. It is found that treatment of Ishikawa cells with ABL127 and AMZ-30 significantly decreases cell proliferation similarly to depletion of PME-1 with shRNA. It is also found that treatment of ECC-1 cells with ABL127 or AMZ-30 affects cell invasion in a dose-dependent manner. The treatment of EC cells with ABL127 leads to a significant ~45 % increase in protein phosphatase 2A (PP2A) activity, while treatment with AMZ-30 leads to a modest ~10 % increase in PP2A activity[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

No significant decrease in tumor burden can be assessed in these pilot studies[1]. Gel-based profiles indicate that brain PME-1 is inactivated by ABL127, but overlapping serine hydrolase activities preclude a confident assessment of the extent of inactivation[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

332.35

Formula

C17H20N2O5

CAS 号

1073529-41-5

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Pure form -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献
  • [1]. Pusey M, et al. Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models. Tumour Biol. 2016 Sep;37(9):11835-11842.

    [2]. Bachovchin DA, et al. Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6811-6.

Kinase Assay
[1]

Human PME-1 protein lacking the last three amino acids (PME-1des3) is purified from Sf9 cells. The assay is completed by first conducting a 10 min pre-incubation of 1 μM PME-1des3 with 100 μM ABL127, 100 μM AMZ-30, 100 μM EHT, or vehicle (0.05 % DMSO) in the presence of SYBR Orange (1:1000, v/v) at 37°C in 1× NEB buffer 2 (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT, pH 7.9 at 25 °C); a thermal gradient is performed increasing temperature by 2°C per minute increments from 37 to 95°C, and fluorescence (492 to 610 nm) is acquired on a thermal cycler[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Assay
[1]

Cells are subjected to 5 μg/mL puromycin selection for 10 to 14 days and are clonally expanded. Validated clones are incubated with media and compounds (including ABL127) for the indicated times for phenotypic assays[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Administration
[1]

ECC-1 cells are subcutaneously inoculated into the flanks of female SCID mice and are allowed to grow until tumors reached ~400 mm3. A single intratumoral dose of ABL127 diluted in 10% DMSO/PBS is administered. The highest concentration tested is 5 mg/kg of ABL127 due to poor solubility of the compound[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

参考文献
  • [1]. Pusey M, et al. Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models. Tumour Biol. 2016 Sep;37(9):11835-11842.

    [2]. Bachovchin DA, et al. Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6811-6.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Abl Cytosolic Substrate

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Abl Cytosolic Substrate 

Abl Cytosolic Substrate是Abl 酪氨酸激酶的底物。Abl 蛋白酪氨酸激酶是v-AbI蛋白酪氨酸激酶的一种截断形式,是Abelson小鼠白血病病毒Gag-Abl融合蛋白的一个伙伴。

Abl Cytosolic Substrate

Abl Cytosolic Substrate Chemical Structure

CAS No. : 168202-46-8

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Abl Cytosolic Substrate is a substrate for Abelson tyrosine kinase (Abl ). Abl Protein Tyrosine Kinase (AbI) is a truncated form of the v-AbI Protein Tyrosine Kinase, a partner in the Gag-Abl fusion protein of the Abelson murine leukemia virus[1].

分子量

1336.58

Formula

C64H101N15O16

CAS 号

168202-46-8

Sequence

Glu-Ala-Ile-Tyr-Ala-Ala-Pro-Phe-Ala-Lys-Lys-Lys

Sequence Shortening

EAIYAAPFAKKK

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

Solvent & Solubility
In Vitro: 

H2O

Peptide Solubility and Storage Guidelines:

1.  Calculate the length of the peptide.

2.  Calculate the overall charge of the entire peptide according to the following table:

  Contents Assign value
Acidic amino acid Asp (D), Glu (E), and the C-terminal -COOH. -1
Basic amino acid Arg (R), Lys (K), His (H), and the N-terminal -NH2 +1
Neutral amino acid Gly (G), Ala (A), Leu (L), Ile (I), Val (V), Cys (C), Met (M), Thr (T), Ser (S), Phe (F), Tyr (Y), Trp (W), Pro (P), Asn (N), Gln (Q) 0

3.  Recommended solution:

Overall charge of peptide Details
Negative (<0) 1.  Try to dissolve the peptide in water first.
2.  If water fails, add NH4OH (<50 μL).
3.  If the peptide still does not dissolve, add DMSO (50-100 μL) to solubilize the peptide.
Positive (>0) 1.  Try to dissolve the peptide in water first.
2.  If water fails, try dissolving the peptide in a 10%-30% acetic acid solution.
3.  If the peptide still does not dissolve, try dissolving the peptide in a small amount of DMSO.
Zero (=0) 1.  Try to dissolve the peptide in organic solvent (acetonitrile, methanol, etc.) first.
2.  For very hydrophobic peptides, try dissolving the peptide in a small amount of DMSO, and then dilute the solution with water to the desired concentration.
参考文献
  • [1]. Buchdunger E, et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res. 1996 Jan 1;56(1):100-4.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

PROTAC BCR-ABL1 ligand 1

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

PROTAC BCR-ABL1 ligand 1 

PROTAC BCR-ABL1 ligand 1,化合物 GMB-475, 是靶向蛋白水解的嵌合体 (PROTAC) 的配体,其以变构方式靶向 BCR-ABL1 蛋白并募集 E3 连接酶 Von Hippel-Lindau,从而导致泛素化和随后的 BCR-ABL1 蛋白的降解。

PROTAC  BCR-ABL1 ligand 1

PROTAC BCR-ABL1 ligand 1 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

PROTAC BCR-ABL1 ligand 1, compound GMB-475, is the ligand of PROTAC that allosterically targets BCR-ABL1 protein and recruits the E3 ligase Von Hippel-Lindau, resulting in ubiquitination and subsequent degradation of BCR-ABL1[1].

体外研究
(In Vitro)

GMB-475 (0-10 μM) exhibits cell proferation with IC50 values of 1.11,1.98,0.37 μM for BCR-ABL1 WT, T315I, G250E cells, respectively[1].
GMB-475 (0-30 μM) induces the degradation of BCR-ABL1 and c-ABL1 with concomitant inhibition of downstream signaling via the STAT5 pathway, in a dose- and time-dependent fashion in the context of both K562 and Ba/F3 cells[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: K562 and Ba/F3 cells
Concentration: 0-30 μM
Incubation Time:
Result: Decreased p-STAT5 expression.

分子量

347.29

Formula

C17H12F3N3O2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Burslem GM, et al. Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation. Cancer Res. 2019 Sep 15;79(18):4744-4753.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

SNIPER(ABL)-020

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

SNIPER(ABL)-020  纯度: 99.44%

SNIPER(ABL)-020,由 Dasatinib (ABL 抑制剂) 通过 linker 与 Bestatin (IAP 配体) 组合而成,可有效降解 BCR-ABL 蛋白。

SNIPER(ABL)-020

SNIPER(ABL)-020 Chemical Structure

规格 价格 是否有货 数量
5 mg ¥8500 In-stock
10 mg ¥14500 In-stock
50 mg ¥38000 In-stock
100 mg   询价  
200 mg   询价  

* Please select Quantity before adding items.

SNIPER(ABL)-020 相关产品

相关化合物库:

  • Bioactive Compound Library Plus

生物活性

SNIPER(ABL)-020, conjugating Dasatinib (ABL inhibitor) to Bestatin (IAP ligand) with a linker, induces the reduction of BCR-ABL protein[1].

分子量

923.52

Formula

C44H59ClN10O8S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

溶解性数据
In Vitro: 

DMSO : 200 mg/mL (216.56 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.0828 mL 5.4141 mL 10.8281 mL
5 mM 0.2166 mL 1.0828 mL 2.1656 mL
10 mM 0.1083 mL 0.5414 mL 1.0828 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (stored under nitrogen)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 5 mg/mL (5.41 mM); Clear solution

    此方案可获得 ≥ 5 mg/mL (5.41 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 50.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液

  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 5 mg/mL (5.41 mM); Suspended solution; Need ultrasonic

    此方案可获得 5 mg/mL (5.41 mM) 的均匀悬浊液,悬浊液可用于口服和腹腔注射。

    以 1 mL 工作液为例,取 100 μL 50.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
*以上所有助溶剂都可在 上海金畔生物科技有限公司 网站选购。
参考文献
  • [1]. Shibata N, et al. Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands. Cancer Sci. 2017 Aug;108(8):1657-1666.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Asciminib hydrochloride(Synonyms: ABL001 hydrochloride)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Asciminib hydrochloride (Synonyms: ABL001 hydrochloride)

Asciminib (ABL001) hydrochloride 是一种有效和选择性的变构 BCR-ABL1 抑制剂,抑制 Ba/F3 细胞生长的 IC50 值为 0.25 nM。

Asciminib hydrochloride(Synonyms: ABL001 hydrochloride)

Asciminib hydrochloride Chemical Structure

CAS No. : 2119669-71-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Asciminib hydrochloride 的其他形式现货产品:

Asciminib

生物活性

Asciminib (ABL001) hydrochloride is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM[1].

体外研究
(In Vitro)

Asciminib (ABL001) hydrochloride binds to the myristoyl pocket of ABL1 and induces the formation of an inactive kinase conformation[1].
Asciminib hydrochloride binds potently (dissociation constant=0.5-0.8 nM) and selectively to the myristoyl pocket of ABL1 and induces the inactive C-terminal helix conformation. Asciminib hydrochloride exhibits the same non-ATP-competitive biochemical kinetics as the BCR–ABL inhibitor GNF-2 but with approximately 100-fold greater potency[1].
Asciminib hydrochloride lacks activity against more than 60 kinases, including SRC, and is similarly inactive against G-protein-coupled receptors, ion channels, nuclear receptors and transporters[1].
In BCR–ABL1-transformed Ba/F3 cells grown without IL-3, Asciminib hydrochloride has an anti-proliferative with IC50 value of 0.25 nM. In the CML blast-phase cell line KCL-22, Asciminib hydrochloride inhibits phosphorylation of both STAT5 (Tyr694; pSTAT5) and BCR–ABL1 (Tyr245; pBCR–ABL1) after 1 h using concentrations that correlate with those required for inhibition of cell proliferation[1].
Asciminib hydrochloride is selectively active against all BCR–ABL1 lines (IC50 value of 1–20 nM), irrespective of the presence of either the p210 or the p190 BCR–ABL1 isoform[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Single doses of 7.5, 15 and 30 mg/kg Asciminib, administered to mice bearing KCL- 22 xenografts, inhibits pSTAT5 (Tyr694), which return to baseline at 10, 12 and 16-20 h after administration of the dose, respectively. In mice implanted with KCL-22 tumors, the minimum dose of Asciminib required for complete regression is 7.5 mg/kg twice a day (BID) or 30 mg/kg once a day (QD), and is tolerated at doses up to 250 mg/kg BID[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

486.30

Formula

C20H19Cl2F2N5O3

CAS 号

2119669-71-3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Wylie AA, et al. The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1. Nature. 2017 Mar 30;543(7647):733-737.

Cell Assay

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

参考文献
  • [1]. Wylie AA, et al. The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1. Nature. 2017 Mar 30;543(7647):733-737.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

SHIMADZU日本岛津分析天平AP135W

SHIMADZU日本岛津分析天平AP135W

  • 品牌 岛津|SHIMADZU
  • 型号 AP135W
  • 可选配件及服务

    SHIMADZU日本岛津分析天平AP135W

    SHIMADZU日本岛津分析天平AP135W

    岛津 比重测定配件 SMK 601

    ¥5800.00

    SHIMADZU日本岛津打印机EP-110

    ¥3100.00

    静电消除器STABLO-AP

    ¥9000.00

    SHIMADZU日本岛津分析天平AP135W

    请询价

    商品详情

    快速:

    采用新型质量传感器UniBloc AP,反应速度和稳定性均得以大幅提升。可实现快速稳定的测量。

    采用新处理方法软件(AP-I系统),提升测量操作感,让您更舒适和自由地使用天平。

    可靠:

    消除静电对测量的影响,确保可靠的测量结果。(需要选配件STABLO-AP)

    操作简便:

    标准配备USB和RS232C连接器。可同时向打印机和PC输出数据。通过USB主设备(W系列配备),可连接USB存储器、键盘、条形码识别器。

    采用在黑暗处也可清晰看清屏幕的“有机EL显示器”。

    支持用户检查天平的功能。选择检查功能,操作界面即显示检查操作步骤。

    标准配备缓冲溶液的制备模式,样品制备模式,调配配方模式等。

    安全可靠的用户管理功能

    符合ISO/GMP/GLP的打印功能

    Labsolutions balance可实现天平称量数据在数据库中的一元化管理

    型号

    量程

    精度

    重复性

    线性

    平均响应时间

    称盘尺寸

    AP135W

    135g

    0.01mg

    0.05mg

    0.1mg

    8s

    91mm

    AP125WD

    120g/52g

    0.1mg/0.01mg

    0.1mg/0.02mg

    0.2mg/0.05mg

    2s/8s

    91mm

    AP225WD

    220g/102g

    0.1mg/0.01mg

    0.1mg/0.05mg

    0.2mg/0.1mg

    2s/8s

    91mm

    AP124W

    120g

    0.1mg

    0.1mg

    0.2mg

    2s

    91mm

    AP224W

    220g

    0.1mg

    0.1mg

    0.2mg

    2s

    91mm

    AP324W

    320g

    0.1mg

    0.15mg

    0.3mg

    2s

    91mm

    AP124X

    120g

    0.1mg

    0.1mg

    0.2mg

    2s

    91mm

    AP224X

    220g

    0.1mg

    0.1mg

    0.2mg

    2s

    91mm

    AP324X

    320g

    0.1mg

    0.15mg

    0.3mg

    2s

    91mm

    AP124Y

    120g

    0.1mg

    0.1mg

    0.2mg

    2s

    91mm

    AP224Y

    220g

    0.1mg

    0.1mg

    0.2mg

    2s

    91mm

    AP324Y

    320g

    0.1mg

    0.15mg

    0.3mg

    2s

    91mm

  • ABL-L

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    ABL-L 

    ABL-L通过p53依赖的途径诱导人喉癌细胞凋亡。

    ABL-L

    ABL-L Chemical Structure

    CAS No. : 1613152-39-8

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    ABL-L induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway.

    分子量

    490.67

    Formula

    C29H46O6

    CAS 号

    1613152-39-8

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Han YY, et al. A new semisynthetic 1-O-acetyl-6-O-lauroylbritannilactone induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway. Toxicol In Vitro. 2016 Sep;35:112-20.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    ABL-L

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    ABL-L 

    ABL-L通过p53依赖的途径诱导人喉癌细胞凋亡。

    ABL-L

    ABL-L Chemical Structure

    CAS No. : 1613152-39-8

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    ABL-L induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway.

    分子量

    490.67

    Formula

    C29H46O6

    CAS 号

    1613152-39-8

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Han YY, et al. A new semisynthetic 1-O-acetyl-6-O-lauroylbritannilactone induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway. Toxicol In Vitro. 2016 Sep;35:112-20.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    ABL-L

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    ABL-L 

    ABL-L通过p53依赖的途径诱导人喉癌细胞凋亡。

    ABL-L

    ABL-L Chemical Structure

    CAS No. : 1613152-39-8

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    ABL-L induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway.

    分子量

    490.67

    Formula

    C29H46O6

    CAS 号

    1613152-39-8

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Han YY, et al. A new semisynthetic 1-O-acetyl-6-O-lauroylbritannilactone induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway. Toxicol In Vitro. 2016 Sep;35:112-20.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    BCR-ABL-IN-4

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    BCR-ABL-IN-4 

    BCR-ABL-IN-4 是一种 BCR-ABLL 抑制剂,具有抗癌作用。BCR-ABL-IN-4 抑制癌细胞生长,对 K562 细胞和 BCR-ABL T315I 转染的 Ba/F3 细胞的 IC50 值分别为 0.67 nM 和 16 nM (WO2021143927A1;化合物 11)。

    BCR-ABL-IN-4

    BCR-ABL-IN-4 Chemical Structure

    CAS No. : 2669790-59-2

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    BCR-ABL-IN-4 is a BCR-ABL inhibitor with anticancer effects. BCR-ABL-IN-4 inhibits the cancer cell growth with IC50 values of 0.67 nM and 16 nM for K562 cells and BCR-ABL T315I transfected Ba/F3 cells, respectively (WO2021143927A1; compound 11)[1].

    分子量

    555.96

    Formula

    C27H24ClF2N5O4

    CAS 号

    2669790-59-2

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Yinsheng Zhang, et al. Compound acting as bcr-abl inhibitor. WO2021143927A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    BCR-ABL-IN-4

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    BCR-ABL-IN-4 

    BCR-ABL-IN-4 是一种 BCR-ABLL 抑制剂,具有抗癌作用。BCR-ABL-IN-4 抑制癌细胞生长,对 K562 细胞和 BCR-ABL T315I 转染的 Ba/F3 细胞的 IC50 值分别为 0.67 nM 和 16 nM (WO2021143927A1;化合物 11)。

    BCR-ABL-IN-4

    BCR-ABL-IN-4 Chemical Structure

    CAS No. : 2669790-59-2

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    BCR-ABL-IN-4 is a BCR-ABL inhibitor with anticancer effects. BCR-ABL-IN-4 inhibits the cancer cell growth with IC50 values of 0.67 nM and 16 nM for K562 cells and BCR-ABL T315I transfected Ba/F3 cells, respectively (WO2021143927A1; compound 11)[1].

    分子量

    555.96

    Formula

    C27H24ClF2N5O4

    CAS 号

    2669790-59-2

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Yinsheng Zhang, et al. Compound acting as bcr-abl inhibitor. WO2021143927A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    BCR-ABL-IN-4

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    BCR-ABL-IN-4 

    BCR-ABL-IN-4 是一种 BCR-ABLL 抑制剂,具有抗癌作用。BCR-ABL-IN-4 抑制癌细胞生长,对 K562 细胞和 BCR-ABL T315I 转染的 Ba/F3 细胞的 IC50 值分别为 0.67 nM 和 16 nM (WO2021143927A1;化合物 11)。

    BCR-ABL-IN-4

    BCR-ABL-IN-4 Chemical Structure

    CAS No. : 2669790-59-2

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    BCR-ABL-IN-4 is a BCR-ABL inhibitor with anticancer effects. BCR-ABL-IN-4 inhibits the cancer cell growth with IC50 values of 0.67 nM and 16 nM for K562 cells and BCR-ABL T315I transfected Ba/F3 cells, respectively (WO2021143927A1; compound 11)[1].

    分子量

    555.96

    Formula

    C27H24ClF2N5O4

    CAS 号

    2669790-59-2

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Yinsheng Zhang, et al. Compound acting as bcr-abl inhibitor. WO2021143927A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    c-ABL-IN-4

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    c-ABL-IN-4 

    c-ABL-IN-4 是一种有效的 c-Abl 抑制剂。c-Abl 的激活与多种疾病有关,尤其是癌症。c-ABL-IN-4 具有研究神经退行性疾病(肌萎缩侧索硬化症 (ALS) 和帕金森病 (PD) 和癌症的潜力) (摘自专利 WO2021048567A1,化合物 54)。

    c-ABL-IN-4

    c-ABL-IN-4 Chemical Structure

    CAS No. : 2626934-68-5

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    c-ABL-IN-4 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-4 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 54)[1].

    分子量

    409.75

    Formula

    C18H11ClF3N3O3

    CAS 号

    2626934-68-5

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    c-ABL-IN-4

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    c-ABL-IN-4 

    c-ABL-IN-4 是一种有效的 c-Abl 抑制剂。c-Abl 的激活与多种疾病有关,尤其是癌症。c-ABL-IN-4 具有研究神经退行性疾病(肌萎缩侧索硬化症 (ALS) 和帕金森病 (PD) 和癌症的潜力) (摘自专利 WO2021048567A1,化合物 54)。

    c-ABL-IN-4

    c-ABL-IN-4 Chemical Structure

    CAS No. : 2626934-68-5

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    c-ABL-IN-4 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-4 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 54)[1].

    分子量

    409.75

    Formula

    C18H11ClF3N3O3

    CAS 号

    2626934-68-5

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    c-ABL-IN-4

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    c-ABL-IN-4 

    c-ABL-IN-4 是一种有效的 c-Abl 抑制剂。c-Abl 的激活与多种疾病有关,尤其是癌症。c-ABL-IN-4 具有研究神经退行性疾病(肌萎缩侧索硬化症 (ALS) 和帕金森病 (PD) 和癌症的潜力) (摘自专利 WO2021048567A1,化合物 54)。

    c-ABL-IN-4

    c-ABL-IN-4 Chemical Structure

    CAS No. : 2626934-68-5

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    c-ABL-IN-4 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-4 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 54)[1].

    分子量

    409.75

    Formula

    C18H11ClF3N3O3

    CAS 号

    2626934-68-5

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    c-ABL-IN-2

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    c-ABL-IN-2 

    c-ABL-IN-2 是一种有效的 c-Abl 抑制剂。c-Abl 的激活与多种疾病有关,尤其是癌症。c-ABL-IN-2 具有研究神经退行性疾病(肌萎缩侧索硬化症 (ALS)和帕金森病 (PD) 和癌症的潜力) (摘自专利 WO2020260871A1,化合物 25) .

    c-ABL-IN-2

    c-ABL-IN-2 Chemical Structure

    CAS No. : 2574593-54-5

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-2 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2020260871A1, compound 25)[1].

    分子量

    344.41

    Formula

    C21H20N4O

    CAS 号

    2574593-54-5

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Rebecca PAUL, et al. New compounds and methods. Patent WO2020260871A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    c-ABL-IN-3

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    c-ABL-IN-3 

    c-ABL-IN-3 是一种有效的 c-Abl 抑制剂。c-Abl 的激活与多种疾病有关,尤其是癌症。c-ABL-IN-3 具有研究神经退行性疾病(肌萎缩侧索硬化症 (ALS) 和帕金森病 (PD) 和癌症的潜力) (摘自专利 WO2021048567A1,化合物 50)。

    c-ABL-IN-3

    c-ABL-IN-3 Chemical Structure

    CAS No. : 2626934-64-1

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    c-ABL-IN-3 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-3 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 50)[1].

    分子量

    376.29

    Formula

    C17H11F3N4O3

    CAS 号

    2626934-64-1

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    c-ABL-IN-2

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    c-ABL-IN-2 

    c-ABL-IN-2 是一种有效的 c-Abl 抑制剂。c-Abl 的激活与多种疾病有关,尤其是癌症。c-ABL-IN-2 具有研究神经退行性疾病(肌萎缩侧索硬化症 (ALS)和帕金森病 (PD) 和癌症的潜力) (摘自专利 WO2020260871A1,化合物 25) .

    c-ABL-IN-2

    c-ABL-IN-2 Chemical Structure

    CAS No. : 2574593-54-5

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-2 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2020260871A1, compound 25)[1].

    分子量

    344.41

    Formula

    C21H20N4O

    CAS 号

    2574593-54-5

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Rebecca PAUL, et al. New compounds and methods. Patent WO2020260871A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    c-ABL-IN-3

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    c-ABL-IN-3 

    c-ABL-IN-3 是一种有效的 c-Abl 抑制剂。c-Abl 的激活与多种疾病有关,尤其是癌症。c-ABL-IN-3 具有研究神经退行性疾病(肌萎缩侧索硬化症 (ALS) 和帕金森病 (PD) 和癌症的潜力) (摘自专利 WO2021048567A1,化合物 50)。

    c-ABL-IN-3

    c-ABL-IN-3 Chemical Structure

    CAS No. : 2626934-64-1

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    c-ABL-IN-3 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-3 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 50)[1].

    分子量

    376.29

    Formula

    C17H11F3N4O3

    CAS 号

    2626934-64-1

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

    c-ABL-IN-2

    上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

    c-ABL-IN-2 

    c-ABL-IN-2 是一种有效的 c-Abl 抑制剂。c-Abl 的激活与多种疾病有关,尤其是癌症。c-ABL-IN-2 具有研究神经退行性疾病(肌萎缩侧索硬化症 (ALS)和帕金森病 (PD) 和癌症的潜力) (摘自专利 WO2020260871A1,化合物 25) .

    c-ABL-IN-2

    c-ABL-IN-2 Chemical Structure

    CAS No. : 2574593-54-5

    规格 是否有货
    100 mg   询价  
    250 mg   询价  
    500 mg   询价  

    * Please select Quantity before adding items.

    生物活性

    c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-2 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2020260871A1, compound 25)[1].

    分子量

    344.41

    Formula

    C21H20N4O

    CAS 号

    2574593-54-5

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    参考文献
    • [1]. Rebecca PAUL, et al. New compounds and methods. Patent WO2020260871A1.

    所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务